As of 2025-11-19, the Relative Valuation of CytomX Therapeutics Inc (CTMX) is 3.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.66 USD, the upside of CytomX Therapeutics Inc based on Relative Valuation is 7.0%.
The range of the Relative Valuation is 3.01 - 5.13 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 20.6x | 19.2x |
| Forward P/E multiples | 27.7x - 35.3x | 31.5x |
| Fair Price | 3.01 - 5.13 | 3.92 |
| Upside | -17.7% - 40.1% | 7.0% |
| Date | P/E |
| 2025-11-17 | 20.89 |
| 2025-11-14 | 22.84 |
| 2025-11-13 | 22.72 |
| 2025-11-12 | 24.90 |
| 2025-11-11 | 24.13 |
| 2025-11-10 | 24.66 |
| 2025-11-07 | 21.31 |
| 2025-11-06 | 24.66 |
| 2025-11-05 | 24.78 |
| 2025-11-04 | 24.07 |
| 2025-11-03 | 23.13 |
| 2025-10-31 | 21.01 |
| 2025-10-30 | 19.60 |
| 2025-10-29 | 19.19 |
| 2025-10-28 | 19.54 |
| 2025-10-27 | 19.78 |
| 2025-10-24 | 19.19 |
| 2025-10-23 | 19.42 |
| 2025-10-22 | 19.95 |
| 2025-10-21 | 21.28 |
| 2025-10-20 | 22.01 |
| 2025-10-17 | 18.83 |
| 2025-10-16 | 19.31 |
| 2025-10-15 | 20.07 |
| 2025-10-14 | 20.13 |
| 2025-10-13 | 20.01 |
| 2025-10-10 | 19.78 |
| 2025-10-09 | 20.31 |
| 2025-10-08 | 19.84 |
| 2025-10-07 | 19.60 |
| 2025-10-06 | 19.31 |
| 2025-10-03 | 19.42 |
| 2025-10-02 | 19.31 |
| 2025-10-01 | 19.72 |
| 2025-09-30 | 18.78 |
| 2025-09-29 | 19.01 |
| 2025-09-26 | 17.07 |
| 2025-09-25 | 16.72 |
| 2025-09-24 | 14.18 |
| 2025-09-23 | 12.42 |
| 2025-09-22 | 12.12 |
| 2025-09-19 | 11.65 |
| 2025-09-18 | 12.01 |
| 2025-09-17 | 11.36 |
| 2025-09-16 | 11.54 |
| 2025-09-15 | 11.71 |
| 2025-09-12 | 11.77 |
| 2025-09-11 | 12.30 |
| 2025-09-10 | 12.18 |
| 2025-09-09 | 12.30 |